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RESUMO 
Nesta dissertação foram estudados índices obtidos a partir de traçados 
eletrocardiográficos convencionais, com o objetivo de avaliar o desequilíbrio 
autonômico e os mecanismos de arritmogênese aumentada, ambos já 
reconhecidamente envolvidos com a progressão da doença mitral em cães. Para 
tanto, este trabalho foi subdividido em introdução e três capítulos. Inicialmente, 
procurou-se esclarecer sobre os aspectos etiológicos e fisiopatológicos da doença, 
dando ênfase para a ativação crônica de mecanismos compensatórios e 
desenvolvimento de arritmogênese, assim como seu papel no que tange à evolução 
e prognóstico. No primeiro capítulo, investigou-se o uso do índice de tônus 
vasovagal (VVTI), um indicador não convencional de atividade parassimpática, e seu 
comportamento nos diferentes estágios da doença mitral. Resultados mostraram que 
o referido índice é capaz de diferenciar cães em estágios diferentes da doença, no 
que diz respeito ao remodelamento cardíaco e à presença de sintomatologia clínica 
atribuída à insuficiência cardíaca congestiva. O segundo capítulo está centrado na 
avaliação do prejuízo no equilíbrio autonômico que acompanha a progressão da 
insuficiência valvar mitral. Para tanto, empregou-se uma manobra vagal amplamente 
descrita para demonstrar a resposta parassimpática fisiológica e, à medida que a 
insuficiência mitral se agrava, a atenuação dessa resposta. O estudo mostrou que é 
possível identificar indivíduos com doença cardíaca avançada com base na resposta 
individual ao reflexo óculo-cardíaco. Não obstante, os resultados obtidos ajudam a 
compreender a complexa desregulação autonômica na síndrome insuficiência 
cardíaca congestiva. Finalmente, o terceiro capítulo foca no estudo do 
prolongamento e da instabilidade do intervalo eletrocardiográfico QT com vistas à 
identificação do estado de arritmogênese aumentada na degeneração válvula mitral. 
O estudo mostrou que prolongamento e instabilidade não só estão presentes, como 
se intensificam conforme a doença progride, sendo os índices estudados capazes de 
identificar remodelamento cardíaco e arritmias ventriculares. Os achados deste 
estudo reforçam a presença de distúrbios de repolarização na doença valvar mitral e 
chamam a atenção para o potencial prognóstico dos índices ligados à instabilidade 
do QT, haja vista a constatação de que o aumento de tais parâmetros está 
associado com menor sobrevida do cão com doença valvar mitral. 
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ABSTRACT 
The aim of this study was to evaluate the autonomic imbalance and 
mechanisms of increased arrhythmogenesis, obtained through conventional 
electrocardiographic tracings, which are known to be involved in the progression of 
mitral disease in dogs. For this purpose, this work was subdivided in introduction and 
three independent chapters. Initially, an attempt was made to clarify the etiological 
and pathophysiological aspects of the disease, emphasizing the chronic activation of 
compensatory mechanisms and the development of arrhythmogenesis, as well as its 
role in disease evolution and prognosis. In the first chapter, we investigated the use 
of the vasovagal tonus index (VVTI), an unconventional indicator of parasympathetic 
activity, and its behavior in different stages of mitral disease. The results showed that 
this index is capable of differentiating dogs at different stages of the disease, 
regarding cardiac remodeling and the presence of clinical symptomatology attributed 
to congestive heart failure. The second chapter is centered on the assessment of the 
impairment in autonomic balance that accompanies the progression of mitral valve 
insufficiency. For this purpose, a widely described vagal maneuver was used to 
demonstrate the physiological parasympathetic response and, as mitral regurgitation 
increases, the attenuation of this response. The study showed that it is possible to 
identify individuals with advanced heart disease based on individual response to the 
oculo-cardiac reflex. Nonetheless, the results obtained help to understand the 
complex autonomic dysregulation in congestive heart failure syndrome. Finally, the 
third chapter focuses on the study of the prolongation and instability of the 
electrocardiographic QT interval with the intent to identifying the state of increased 
arrhythmogenesis in mitral valve degeneration. The study showed that prolongation 
and instability are not only present, but also intensify as the disease progresses, and 
the indices studied are capable of identifying cardiac remodeling and ventricular 
arrhythmias. The findings of this study reinforce the presence of repolarization 
disorders in mitral valve disease and draw attention to the potential prognostic values 
of the indexes related to QT instability, given that the increase in these parameters is 
associated with lower survival of the dog with Mitral valve disease. 
 
Key-words: electrocardiography, autonomic imbalance, mitral insufficiency, QT 
interval, arrhythmias 
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INTRODUÇÃO 
 
Myxomatous mitral valve disease (MMVD), also known as endocardiosis, is 
frequently responsible for mitral regurgitation in dogs, and represents the most 
common acquired heart disease in that species (Atkins et al, 2009). Although many 
causes have been speculated, it is most often a primary condition, being more 
frequent in small to medium size dogs (Freed et al., 2002). The existence of breeds 
particularly predisposed to the disease, such as the Cavalier King Charles Spaniel, 
Dachshunds, Miniature Poodles and Schnauzers, support the hypothesis of a 
determinant hereditary component. Researches carried out in attempt to identify 
genes associated to disease predisposition suggest a polygenic inheritance, with 
variable penetrance (Meurs et al, 2010). Males are around 1.5 times more frequently 
affected than females, in addition to presenting earlier onsets and faster disease 
progression (Atkins et al., 2009). From anatomopathological studies, it has been 
observed that dogs develop MMVD with age, which makes this disease very similar 
micro and macroscopically to mitral valve prolapse in people (Pedersen et al., 2000). 
With the exception of the Cavalier King Charles Spaniel and other possible 
genetically predisposed breeds, MMVD is uncommon in young dogs.  However, it 
has a prevalence of over 90% in dogs of 10 years or older (Atkins et al., 2009). The 
progression of mitral valve disease is variable, resulting in assymptomatic patients for 
life, or in dogs evolving to death in a few months due to congestive heart failure 
(CHF) (Borgarelli et al, 2008).  
MMVD is characterized by an abnormal protrusion of the mitral valve into the left 
atrium, resulting from the continuous deposition of glycosaminoglycans in the leaflets 
and tendon chordae (Freed et al., 2002). Little is known about the molecular 
mecanisms involved in the pathophysiology of the disease, but studies indicate that, 
similar to what happens in valve disease in human beings, increased levels of 
serotonin (5HT) signaling may be present. A research proved that predisposed dogs 
and/or dogs with naturally-occurring mitral valve disease have significantly increased 
levels of circulating 5-HT when compared to healthy subjects (Arndt et al., 2009). 
Another investigation that focused on the genomic expression of the mitral valve 
tissue also identified inflamatory cytokines and growing transforming factor beta as 
important contributors to the patophysiology of the disease (Oyama et al., 2006). In a 
histologic level, MMVD turns the originally thin and translucent valvar leaflets into 
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thick and opaque structures that evolve into nodules and deformation (Philip, 2012). 
The thickening of theses leaflets, along with the changes in colagenous fibers of the 
cordoalia due to senility, reduce the ability of the valve to resist to the mechanical 
stress imposed during systole, resulting in non-cooptation of the leaflets and 
retrograde blood flow, from the ventricle to the atrium (Whitney, 1974). The mitral 
valve is damaged alone in approximately 62% of the cases, while both atrial-
ventricular valves are involved in 33% of the cases. Interestingly, the isolated 
degeneration of the tricuspid valve is considered uncommon (Atkins, 2009). Due to 
the variable progression of the disease, clinically healthy animals may be diagnosed 
during routine physical examination, by means of the auscultation of a systolic apical 
murmur. As the damage in the leaflets progresses, mitral insufficiency may become 
clinically overt (Borgarelli et al., 2008).  
In MMVD, blood regurgitated to the left atrium causes a decrease in the volume 
ejected by the ventricle at each systole (systolic volume), minimizing the amount of 
blood ejected per minute (cardiac output). In order to avoid significant decreases in 
blood pressure, neurohormonal compensatory mechanisms are activated, which 
include an increase in sympathetic tone and parasympathetic withdrawal, activation 
of the renin-angiotensin-aldosterone system (RAAS) and vasopressin secretion 
(ADH). These mechanisms are effective in maintaining homeostasis in situations of 
acute hypotension and hypovolemia. However, in chronically affected hearts, the 
constant activation of these mechanisms leads to the clinical syndrome known as 
congestive heart failure (CHF), which is characterized by the inability of the heart to 
maintain cardiac output, resulting in inadequate blood distribution and abnormal fluid 
congestion in the organic systems (Ware, 2001).  
  According to the consensus statement of the American College of Veterinary 
Internal Medicine (ACVIM), MMVD may be classified into five stages. Stage A 
represent patients at high risk of developing mitral degeneration, however, without a 
cardiac murmur during auscultation. Stage B1 represents patients with cardiac 
murmur but no clinical signs. Also, these patients have no cardiac remodeling 
observed on radiographic and echocardiographic examinations. Along with the 
cardiac murmur, stage B2 dogs exhibit an enlarged heart (cardiac remodeling) on 
radiographic and echocardiographic exams, but clinical signs of CHF are still not 
present. On the other hand, stage C patients have clinical signs of CHF, which tend 
to respond to the conventional medical therapy, while stage D dogs are in terminal 
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stages of the disease, which make them refractory to the standard medical therapy 
(Atkins et al., 2009) 
Compensatory mechanisms, working together and independently, allow the 
animal with MMVD to antagonize the decrease of blood pressure caused by the 
constant mitral regurgitation. This characteristic explains why affected dogs remain 
asymptomatic for months to years (Borgarelli et al, 2008). However, the chronic 
activation of these mechanisms plays an important role in the progression of the 
disease. The constant activation of the sympathetic nervous system and suppression 
of its parasympathetic counterpart result in a sustained increase in resting heart rate, 
which shortens the diastolic period and increases oxygen consumption by the 
myocardium, reducing cardiac output and resulting in hypoxia-mediated cellular 
death. In addition, augmented peripheral vascular resistance results in increased 
after-load, which rises cardiac energy expenditure. The consequences include a 
reduced cardiac output and an increase in mitral regurgitation MR volume (Ramírez 
et al, 2001). Advanced mitral insufficiency induces cardiac remodeling, which is 
characterized by dilation of the left atrium and ventricle, eccentric myocardial 
hypertrophy and changes in the intercellular matrix (Bonagura and Schober, 2009). 
Remodeling, along with an increase in resting heart rate, can lead to cardiac 
arrhythmias, especially those of atrial and junctional origin (Verheule et al., 2003). 
The term arrhythmia (or dysrhythmia) refers to irregular heart rhythm. The 
pathophysiological causes of arrhythmias include abnormal automaticity of the 
pacemaker cells, pacemaker migration from the sinoatrial node to other areas of the 
heart, conduction blockages that interrupt or delay the normal electrical propagation 
throughout the heartconduction, abnormal pathways of impulse conduction, and 
spontaneous formation of a pulse in a non-specialized heart area (Tilley, 2008). In 
dogs with MMVD, supraventricular extrasystoles and supraventricular tachycardia are 
the rhythm disturbances most commonly diagnosed. Other alterations that may also 
be observed are atrioventricular block (AVB) in various degrees, sinus arrest and 
ventricular arrhythmias (Tilley, 1992). Crosara et al. (2010), in a study that recruited 
36 dogs with MMVD, concluded that the presence of arrhythmias is a common 
finding in those patients regardless of clinical condition. In addition, it was 
documented that atrial dilatation is directly related to the exacerbation of  
supraventricular arrhythmias. Ventricular arrhythmias, however, were significantly 
more frequent in dogs with clinical MMVD. Finally, they showed that rhythm 
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disturbances in MMVD animals rarely result in clinical signs, such as fatigue or 
syncope, which leads to sub-diagnosing.  
Although clinical signs resulting from rhythm disturbances are uncommon in 
dogs with MMVD, there is a concern about the incidence of ventricular arrhythmias in 
these animals because of the increased risk of sudden death and chronic damage 
due to decreased cardiac output (Crosara et al., 2010). In people, it has been 
speculated that arrhythmias may play a significant role in clinical symptoms and may 
be responsible for the slightly increased risk of sudden death in MVP patients. 
Electrocardiographic evidence of conduction disturbances such as unstable 
repolarization dynamics are a known risk factor for arrhythmia (Berger et al., 1997). 
The elucidation of the electrophysiological events underlying rhythm disorders may 
provide surrogate markers that are able to predict the occurrence of life-threatening 
arrhythmias in dogs with advanced MMVD. 
Due to the high incidence of mitral valve disease in the canine population, as 
well as its variable progression rate, surrogates of morbidity and mortality are 
warranted. The existence of a resource that is able to predict when (or if) dogs with 
the benign form of the disease will decompensate, would allow to answer frequent 
questions of the owners regarding survival time, besides optimizing the treatment. 
Although there is still no ideal indicator capable of accurately predicting the 
occurrence of CHF, studies indicate heart rate variability (HRV) as a simple and 
reliable tool (Haagstrom et al, 2009). HRV is a measure of autonomic function used 
to assess the physiological phenomenon of change in heart rate, which is mediated 
by cardiac autonomic tone (Stein et. al. 1994). Decreased HRV values are a common 
finding at advanced stages of CHF, and numerous studies have acknowledged its 
use as a prognostic surrogate in a series of cardiac conditions. Cardiac biomarkers, 
such as serum natriuretic peptides, and echocardiographic indices of remodeling (left 
atrium / aorta ratio) are also considered promising resources (Reynolds et al, 2012). 
Nonetheless, the ideal indicator of morbidity and mortality remains undiscovered 
(Sargent et al., 2015) 
In this dissertation, we studied potentially useful indices of autonomic imbalance and 
impaired ventricular repolarization dynamics obtained from conventional ECG 
tracings. These indices may serve as indicators of morbidity, as well as aid in 
predicting the development of ventricular arrhythmias in dogs with different stages of 
MMVD. 
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CHAPTER 1 - Vasovagal tonus index in dog with myxomatous mitral valve 
disease1 
 
ABSTRACT.- The vasovagal tonus index (VVTI) is an useful and assessable index, 
obtained from standard ECG recordings, that is used to estimate heart rate variability 
(HRV), and may provide valuable information regarding the likelihood of progression 
into congestive heart failure (CHF). In this paperwork, we investigated how the 
vasovagal tonus index (VVTI) behaves in dogs with naturally-occurring myxomatous 
mitral valve disease (MMVD) Electrocardiographic (ECG) recordings and 
echocardiographic data of 120 patients diagnosed with MMVD were reviewed. The 
VVTI was calculated from twenty consecutive RR intervals for each dog enrolled in 
the study. Lower VVTI values were found in MMVD patients in American College of 
Veterinary Internal Medicine (ACVIM) stage C compared with stages B1 and B2. 
Values were also lower in patients with severe cardiac remodeling. When a cut-off 
value of 6.66 is used, VVTI was able to discriminate MMVD patients in stage C from 
B1 and B2 dogs with a sensitivity of 70 per cent and a specificity of 77 per cent. 
MMVD dogs in which VVTI is lower than 6.66 are 30% more likely to develop 
congestive heart failure (CHF). 
INDEX TERMS: heart rate variability, prognosis, autonomic nervous system, 
electrocardiography, congestive heart failure 
 
    1Received on ........... 
     Accepted for publication in .......... 
    2Programa de Pós-Graduação em Ciências Veterinárias, Departamento de 
Medicina Veterinária, Universidade Federal do Paraná (UFPR), Campus Agrárias, 
Juvevê, Rua dos Funcionários 1540, Curitiba, PR 80035-050, Brazil.  
 
RESUMO.- [Índice de tônus vasovagal em cães com doença mixomatosa da 
valva mitral.] O índice de tônus vasovagal (ITVV) é uma ferramenta útil e acessível, 
obtida por meio de traçados eletrocardiográficos convencionais (ECG), utilizada para 
calcular a variabilidade da frequência cardíaca (VFC), podendo também fornecer 
informações valiosas referentes à probabilidade de desenvolvimento de insuficiência 
cardíaca congestiva (ICC). Neste trabalho, foi investigado como o ITVV se comporta 
em cães com degeneração mixomatosa da valva mitral (DMVM) de ocorrência 
natural, ECGs e exames ecocardiográficos de 120 pacientes diagnosticados com 
DMVM foram avaliados. O ITVV foi calculado a partir de 20 intervalos RR 
consecutivos para cada cão envolvido. Valores menores de ITVV foram encontrados 
em pacientes em estágio C de doença mitral pela classificação do American College 
of Veterinary Internal Medicine (ACVIM), comparado com pacientes em estágio B1 e 
B2. Valores também foram menores em pacientes com remodelamento cardíaco 
importante. Quando um valor de corte de 6,66 foi usado, o ITVV foi capaz de 
distinguir pacientes em estágio C de B1 e B2 com uma sensibilidade de 70 por cento 
e uma especificidade de 77 por cento. Cães com DMVM cujo ITVV é menor que 6,66 
são 30% mais propensos a evoluírem para ICC. 
TERMOS DE INDEXAÇÃO: variabilidade da frequência cardíaca, prognóstico, 
sistema nervoso autônomo, eletrocardiografia, insuficiência cardíaca congestiva 
_______________  
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INTRODUCTION 
The ability of the heart to adapt to various conditions by means of change in 
heart rate (HR) is mediated by cardiac autonomic tone (Pomeranz et al. 1985). 
Patterns of increased and decreased HR are a signal of good adaptation and efficient 
autonomic mechanisms, and reflect a healthy heart (Saul et al. 1988). This 
physiological phenomenon can be assessed by a measure of autonomic function 
known as heart rate variability (HRV) (Stein et al. 1994). Therefore, an increase in 
sympathetic tone is followed by a decrease in HRV, while an increase in 
parasympathetic tone results in increased HRV(Montano et al. 2001).  
Analyses of beat-to-beat changes in HR provide sensitive and early 
information of impaired cardiac function. Decreased HRV values are a common 
finding in initial stages of congestive heart failure (CHF) even before clinical signs 
become overt (Task Force 1996), and numerous medical and veterinary studies have 
acknowledged that certain measures of autonomic function may act as a prognostic 
surrogate in various structural cardiovascular conditions (Stein et al 1994, Calvert et 
al. 1998, Nolan et al. 1998, Lahiri et al. 2008). HRV indexes can be obtained by 
linear methods of either time or frequency domain analysis, with a few 
unconventional nonlinear methods also described in people (Vanderlei et al. 2009). 
In most cases, values of HRV are preferably obtained by 24-hour Holter monitoring, 
which is time-consuming and may be laborious to apply in daily clinical practice. In 
this scenario, the vasovagal tonus index (VVTI) stands out as an useful time domain 
indicator of HRV obtained from the standard electrocardiographic data, which does 
not require any specific equipment for its calculation, besides a conventional ECG 
recorder. It is mainly influenced by the parasympathetic tone, whose applicability has 
been recognized in previous studies (Häggstrom 1996, Doxey and Boswood 2004). 
In this prospective cross-sectional observational study, we sought to 
investigate if VVTI is able to identify remodeling, as well as CHF, in dogs with 
naturally occurring mitral valve disease.  
 
MATERIAL AND METHODS 
Dogs were recruited for this study among patients attending routine 
cardiological evaluation in a veterinary hospital. All procedures were conducted in 
accordance with the institutional Animal Use Committee guidelines, under the 
protocol 039/2015. Three-minute ECG tracings were acquired using a computer-
based ECG recorder (ECGP V6, TEB – Brazilian Electronic Technology Ltda., São 
Paulo, SP, Brazil) and echocardiography was carried out using an ultrasonography 
system (MyLab 30 – Esaote, Genova, Italy) equipped with a 5.0 MHz and a 7.5 MHz 
phased array transducers (P240 and P023 reference – Esaote, Genova, Italy).  
In order to be included in the study, dogs needed to be diagnosed with MMVD 
at any stage, based on echocardiographic criteria of impaired valvar anatomy and 
function (Chetboul et al. 2012). Dogs with evidence of any congenital or acquired 
cardiac disease other than degenerative mitral valve disease were excluded from the 
study, along with patients with relevant systemic conditions or undergoing chronic 
medical therapy. After a positive diagnosis, three-minute ECG tracings were acquired 
for each patient. Bad quality recordings and ECG tracings where arrhythmias 
prevented a continuous run of 20 R-R intervals of sinus rhythm were excluded from 
the study, along with ECG tracings of patients being given any antiarrhythmic drug 
when the recording was obtained. Finally, dogs visibly frightened and agitated, along 
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with dogs that would not allow stress-free mechanical contentions were also 
excluded from the study. 
ECG recordings were reviewed and the first 20 consecutive R-R intervals in 
which cardiac rhythm was of sinus origin were used to calculate VVTI for each 
patient. The index was obtained by calculating the natural logarithm of the variance 
of the 20 measured R-R intervals, as described by the equation VVTI = NL [VAR (R-
R1 – R-R20)], where NL: natural logarithm, VAR: variance. Indexes of congestion 
and function obtained by echocardiographic examination, such as left atrium to aorta 
ratio (LA/Ao), body weight-indexed left ventricular internal diameter in diastole and 
systole (BW-indexed LVd and BW-indexed LVs), wall stress index in diastole and 
systole (WSId and WSId), fractional shortening (FS%), mitral E wave velocity (mitral 
E), mitral E-to-A ratio (mitral E/A), isovolumic relaxation time (IVRT) and mitral E-to-
IVRT ratio (E/IVRT) were also documented for each dog on the study. All indexes 
were measured by the same investigator, as to avoid interinvestigator discrepancy. 
For statistical purposes, the dogs were divided into three groups based on left 
atrial remodeling, according to Ljungvall et al. (2005). LA/Ao<1.4, 1.4<LA/Ao<1.8; 
LA/Ao>1.8). LA and Ao diameters were measured at right parasternal window using 
short axis images at the very last frame before aortic valve opening, and left 
ventricular volumes and diameters in systole and diastole were assessed by M-
mode, also in short axis images. (Chetboul et al. 2012). Also, another classification 
was based on the stage of mitral valve disease (B1, B2 and C) proposed by the 
American College of Veterinary Internal Medicine (Atkins et al. 2009), which 
depended on the animal history concerning clinical signs attributable to CHF, as well 
as the echocardiographic proof of left atrial overload.  
All data underwent the Shapiro-Wilk normality test. Either an analysis of 
variance followed by Tukey´s multiple comparison test or the Kruskal-Wallis test 
followed by Dunn’s test was used to investigate differences in VVTI in the studied 
population. Either Pearson’s or Spearman’s test was used to assess whether 
correlations existed between VVTI and heart rate (HR), age and body-weight, as well 
as between VVTI and the echocardiographic parameters. Also, receiver operating 
characteristic (ROC) curves were constructed to investigate sensitivity and specificity 
of VVTI to differentiate MMVD dogs with remodeled hearts from those without 
remodeling, as well as those with overt clinical signs from the asymptomatic animals. 
All analyses were performed using the software GraphPad Prism (Version 5.0 - San 
Diego, CA, USA) using default settings.  For all analyses, the level of significance 
was defined as P<0.05.  
RESULTS 
One hundred and twenty client-owned dogs diagnosed with MMVD were 
recruited at the end of the study. Several breeds were represented, and the age and 
body-weight of the animals varied from 6-18 years and 2.3-15.5 kg, respectively. 
Poodles (33/120) and Miniature Pinschers (17/120) were overrepresented in the 
study population. 
No correlation was found between VVTI and body-weight (P=0.1113), but a 
significant negative correlation was documented between VVTI and HR (P<0.0001), 
as well as between VVTI and age (P=0.0491).  
The three groups of dogs divided according to left atrial size held 40 animals 
each, and differences regarding age (P=0.0598) and body-weight (P=0.2232) did not 
exist between groups. VVTI values based on LA/Ao size are shown in Table 1. A 
significant difference between group LA/Ao>1.8 and the two groups in which LA/Ao 
was lower than 1.8 was documented (P<0.05). The lowest VVTI values were found in 
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dogs with LA/Ao>1.8 whereas the highest values corresponded to the animals with 
LA/Ao<1.4 (Figure 1-A).  
  When the dogs were divided in accordance with the ACVIM consensus 
statement, 40, 60 and 20 animals were assigned into groups B1, B2 and C, 
respectively. Again, no difference was found regarding age (P=0.1532) or body-
weight (P=0.6307) between these three groups. Table 2 brings VVTI values 
distributed within the groups. When VVTI values of patients in groups B1, B2 and C 
were compared, a significant difference between group C and groups B1 and B2 was 
identified (P<0.05). The lowest VVTI values were found in group C, while the highest 
values corresponded to group B1 (Figure 1-B).  
The relationship between VVTI and cardiac rhythms during ECG recording 
was also investigated. The identification of the rhythms was done according to heart 
rate and regularity of the QRS complexes. A sequence of sinus beats, with regular 
intervals and rate within normal for age and breed was classified as sinus rhythm 
(SR). Sinus beats where R-R intervals presented a variation of 10% or higher 
between consecutive beats was classified as sinus arrhythmia (SA). Finally, a 
sequence of sinus beats with increased heart rate regarding age and breed was 
classified as sinus tachycardia (ST) (Tilley 1992). VVTI calculated for dogs with SA 
was significantly different from that calculated for animals presenting either SR or ST. 
The lowest VVTI values were found in the ST group and the highest values 
corresponded to the SA group (Figure 1-C). 
When it comes to echocardiographic indices of congestion and function, no 
correlation was found between VVTI and BW-indexed LVd (R: -0.0919; P=0.3440), 
BW-indexed LVs (R: -0.0634; P=0.5144), WSIs (R: -0.0362; P=0.6943) and FS% (R: 
-0.1043; P=0.2570). On the contrary, a significant correlation was observed between 
VVTI and mitral E wave (R:-0.5377; P<0.0001), mitral E/A (R:-0.4164; P<0.0001), 
IVRT (R:0.3539; P=0.0006), E/IVRT ratio (R:-0.5511; P<0.0001), WSId (R:-0.1931; 
P=0.0346), and LA/Ao (R:-0.4366; P<0.0001) (Figure 2). 
The ROC curve constructed to investigate sensitivity and specificity to 
differentiate dogs with remodeled hearts from those without remodeling found an 
AUC of 0.6802 (95% CI: 0.5815 to 0.7789; P=0.0013) (Figure 3-A). To differentiate 
asymptomatic dogs from those with CHF, an AUC of 0.7778 (95% CI: 0.6574 to 
0.8981; P<0.0001) was observed (Figure 3-B). VVTI cut-off values and its respective 
sensitivity, specificity, and positive likelihood ratio were calculated and are shown in 
Table 3. 
DISCUSSION AND CONCLUSIONS 
In this prospective study, lower VVTI values were found in MMVD dogs in 
stage C as compared to patients in stages B1 and B2. Values <7.385, <6.660 or 
<5.525 are associated with a positive likelihood ratio of 1.82, 3.04 or 10.0, 
respectively, which translates into a dog having a slight (0-15%), moderate (15-30%) 
or large (45%) increase in the probability of being symptomatic (stage C) than 
asymptomatic (either stage B1 or B2). Therefore, the lower the VVTI becomes the 
more suggestive that an asymptomatic MMVD patient may evolve into CHF. This 
finding is extremely valuable for clinical decision making, and is in accordance with 
previously reported data that suggests parasympathetic withdrawal in CHF syndrome 
(Eckberg et. al. 1971, Oliveira et. al. 2012). Left atrial enlargement is associated with 
the progression of MMVD, and the degree of dilation is recognized as a prognostic 
surrogate (Borgarelli et al. 2008, Reynolds et. al. 2012). Because this study 
documented the lower VVTI values in patients with LA/Ao >1.8 as compared to dogs 
with smaller left atriums, VVTI might also be considered a surrogate for CHF. This 
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finding is supported by the results of a retrospective study regarding multiple cardiac 
conditions, where the referred index has proven to be the most useful discriminatory 
parameter for detection of heart failure among a variety of selected laboratory and 
electrocardiographic parameters (Boswood et al. 2006).  
Conventional HRV measures have been studied in people with heart disease, 
and were found to be an excellent predictor of adverse outcome (Saul et al. 1988, 
Nolan et. al. 1998, Lahiri et al. 2008). Time-domain heart rate variability parameters 
have also shown to have prognostic potential for determining the severity of MMVD 
in dogs (Rasmussen et al. 2012, Oliveira et al. 2012). These measures, however, 
usually hold the disadvantage of requiring a 24 hour Holter monitoring. 
In our study, we sought to investigate if an unconventional and straightforward 
measure of HRV, obtained by the analyses of only 20 consecutive RR intervals, 
might be reliable in differentiating MMVD dogs in stages B1, B2, and C. Our results 
suggest that VVTI can discriminate MMVD patients in stage C from B1 and B2 dogs 
with a sensitivity of 70 per cent and a specificity of 77 per cent when a cut-off value of 
6.66 is to be used. 
Previous studies have acknowledged the feasibility of the VVTI as a measure 
of HRV in dogs with cardiac disease. Doxey and Boswood (2004) analyzed its 
diagnostic potential for CHF in 92 dogs of several breeds and different heart 
conditions. In that study, VVTI was shown to be a good diagnostic tool for CHF with a 
sensitivity of 100 per cent and a specificity of 83.6 per cent when a cut-off value of 
6.75 was used. Boswood et al, 2006 analyzed the effects of heart disease, heart 
failure and diuresis on nine selected laboratory and echocardiographic parameters in 
dogs with multiple heart conditions, and observed that the VVTI decreased with the 
onset of CHF, proving to be the most useful discriminatory parameter for this 
syndrome among the tested. Also, Pereira et al. (2008) studied the index’s 
applicability in dogs with dilated cardiomyopathy (DCM) and found the index to be a 
moderately accurate diagnostic tool for the assessment of severity of heart failure in 
DCM patients. When using a cut-off value of 7.59, a good sensitivity of 88.7 per cent 
was calculated, but the specificity of 62.5 per cent was considered low. When it 
comes to MMVD, Häggstrom et al. (1996) investigated the index in Cavalier King 
Charles spaniels, which are known for the rapid progression of MMVD into CHF. In 
their study, VVTI was similar in healthy and early staged subjects, but the index 
became significantly lower in CHF patients. Interestingly, our study is the first one to 
evaluate VVTI applicability in the general population of dogs with MMVD, exclusively. 
Also, this investigation documented significant correlations between VVTI and 
some of the studied echocardiographic parameters. A moderate negative relationship 
was found between the VVTI and mitral E (R:-0.54) and between VVTI and E/IRVT 
(R:-0.55). A weak negative relationship was found between the VVTI and mitral E/A 
(R:-0.42), and VVTI and LA/Ao (R:-0.44). A weak positive relationship was 
documented between VVTI and IVRT (R: 0.35). As reported before, decreased HRV 
values are commonly observed during the initial stages of CHF even before clinical 
signs become evident (Task Force, 1996). In severe cases of mitral valve 
regurgitation, volume overload leads to left atrial and ventricular remodeling, both 
associated with clinical onset (Reynolds et al, 2012). Many echocardiographic indices 
tend to become altered when a still asymptomatic MMVD dog progresses into 
symptomatic CHF. In this study, the significant correlation found regarding the echo 
indices of congestion and function is supportive of VVTI being lower as CHF 
becomes more severe. 
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The negative correlation between VVTI and heart rate is likely ascribed to the 
role played by the parasympathetic tone in VVTI, therefore producing higher values 
when slower rates and irregular rhythms are present. VVTI is a time-domain method 
of analysis and, being acquired over a short period of time, provides information 
about high-frequency variations in heart rate, which are predominantly a result of 
vagal influences (Doxey and Boswood, 2004). This also explains the higher values of 
VVTI in patients presenting sinus arrhythmia when compared to dogs presented with 
sinus rhythm and sinus tachycardia. The influence of the autonomic nervous system 
on the heart is dependent on information from baroreceptors, chemoreceptors, atrial 
and ventricular receptors, among others. Therefore, several factors can interfere with 
HRV, including exercise and physical and mental stress, respiration, blood pressure 
regulation, thermoregulation, and influence of the renin-angiotensin system (Stein et 
al. 1994). Even though these uncontrolled conditions during ECG recording may 
increase HR, the lower VVTI found in animals exhibiting sinus tachycardia may 
reflect high sympathetic and low parasympathetic outflows, commonly found in 
severe cases of MMVD (Häggstrom et al. 1996). As for the negative correlation 
documented between VVTI and age, this is mostly likely due to the late onset and 
progressive nature of MMVD, usually becoming clinically relevant in animals of higher 
ages. 
An important limitation involving the use of VVTI is the impossibility of 
calculation when a consecutive 20-beat recording of sinus rhythm is lacking. In 
severe stages of cardiac remodeling, atrial fibrillation and ventricular premature 
complexes are a common finding during ECG recordings, which invalidate the index 
(Verheule et al. 2003). In our study, arrhythmias did not preclude the calculation of 
the index in the population of dogs, but we do recognize that it might be a limitation in 
the clinical setting. Also, being the VVTI an index influenced mainly by the 
parasympathetic tone, external influences in heart rate, including stress, fear and 
agitation, may result in low values in healthy animals. For this reason, it is 
encouraged that ECG recordings be acquired in a quiet and stress-free environment. 
Finally, the lack of attention in this study regarding possible effects of treatment over 
the index, as documented by Boswood et al. 2006, may need to be taken in 
consideration.  
In conclusion, this study supports the use of VVTI as a nonconventional index 
of HRV that may provide valuable information when assessing the severity of MMVD 
and the likelihood of a patient progressing into CHF. Dogs with VVTI <7.425 are 
slightly more likely to have remodeled hearts (around 15% increase in probability) as 
compared to those in which VVTI is higher, while those with VVTI <5.830 are 
moderately more likely to have dilated cardiac chambers (35-45% increase in 
probability). Also, MMVD dogs in which VVTI is lower than 6.66 have a moderate 
increase of 30% in the probability of evolving into CHF. Knowing how this index 
behaves in this particular canine heart disease may also be useful in studies aimed 
at predicting CHF in human beings with MVP. 
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TABLES AND FIGURES 
 
Table 1. Descriptive statistics of vasovagal tonus index (VVTI) calculated for dogs with myxomatous 
mitral valve disease (MMVD) and divided into groups in accordance with left atrial size. 
 LA/Ao 
P  
(Kruskal-Wallis) 
<1.4 
(n=40) 
1.4-1.8 
(n=40) 
>1.8 
(n=40) 
Minimum 5.710 1.370 2.250 
<0.0001 
25% Percentile 6.798 6.898 5.250 
Median 8.560 a 7.880 a 6.330 b 
75% Percentile 9.285 8.888 7.358 
Maximum 10.51 10.82 9.900 
Coefficient of variation 16.99% 22.51% 25.43% 
 
 
Table 2. Descriptive statistics of vasovagal tonus index (VVTI) calculated for dogs with myxomatous 
mitral valve disease (MMVD) and divided into stages in accordance with the consensus statement 
proposed by the American College of Veterinary Internal Medicine (ACVIM). 
 Stage 
P  
(Kruskal-Wallis) 
B1 
(n=40) 
B2 
(n=60) 
C 
(n=20) 
Minimum 5.710 1.370 2.250 
<0.0001 
25% Percentile 6.798 6.533 4.890 
Median 8.560 a 7.340 a 5.555 b 
75% Percentile 9.285 8.735 7.293 
Maximum 10.51 10.82 9.350 
Coefficient of variation 16.99% 22.51% 29.28% 
 
 
Table 3. Cut-off values and their corresponding sensitivity and specificity indices when using 
vasovagal tonus index (VVTI) to differentiate dogs with remodeled and normal hearts, and 
asymptomatic dogs from those presenting overt clinical signs. 
 VVTI 
cut-off 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Likelihood 
ratio (+) 
N
o
rm
a
l 
v
s
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R
e
m
o
d
e
le
d
 
H
e
a
rt
s
 
< 5.830 22.50 (13.91 to 33.21) 97.50 (86.84 to 99.94) 9.00 
< 6.220 30.00 (20.26 to 41.28) 95.00 (83.08 to 99.39) 6.00 
< 6.860 41.25 (30.35 to 52.82) 72.50 (56.11 to 85.40) 1.50 
< 7.095 50.00 (38.61 to 61.39) 70.00 (53.47 to 83.44) 1.67 
< 7.425 60.00 (48.44 to 70.80) 65.00 (48.32 to 79.37) 1.71 
A
s
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m
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ti
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v
s
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S
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< 5.525 50.00 (27.20 to 72.80) 95.00 (88.72 to 98.36) 10.00 
< 6.220 55.00 (31.53 to 76.94) 85.00 (76.47 to 91.35) 3.67 
< 6.660 70.00 (45.72 to 88.11) 77.00 (67.51 to 84.83) 3.04 
< 7.035 75.00 (50.90 to 91.34) 66.00 (55.85 to 75.18)  2.21 
< 7.385 80.00 (56.34 to 94.27) 56.00 (45.72 to 65.92) 1.82 
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Figure 1 – Box plot depicting the medians, interquartile ranges and amplitude of vasovagal tonus 
index (VVTI) in dogs with myxomatous mitral valve disease (MMVD), subdivided in accordance with 
(A) left atrial remodeling, (B) disease stages and (C) cardiac rhythm during ECG recording. SA: sinus 
arrhythmia; SR: sinus rhythm; ST: sinus tachycardia. 
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Figure 2 – Scatter plots depicting significant correlations between vasovagal tonus index (VVTI) and 
mitral E peak velocity (A), mitral  E-to-A ratio (B), isovolumic relaxation time (IVRT) (C), E-to-IVRT 
ratio (D) and left atrium-to-aorta ratio (E). Bestfit lines and 95% confidence band are shown. 
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Figure 3 – Receiver operating characteristic curves constructed to investigate sensitivity and 
specificity of vasovagval tonus index (VVTI) to differentiate myxomatous mitral valve disease (MMVD) 
dogs with remodeled hearts from those without remodeling (A), as well as those with overt clinical 
signs from the asymptomatic animals (B). 
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CHAPTER 2 - Characterization of the Heart Failure-Induced Autonomic 
Imbalance by Means of the Response to a Vagal Maneuver in a Naturally-
Occuring Model of Valve Insufficiency in Dogs2 
 
ABSTRACT 
Congestive heart failure is characterized by reduced heart rate variability. 
Although parasympathetic withdrawal and sympathetic activation have previously 
been documented, a vagal maneuver was never used to assess the autonomic 
impairment associated with disease progression. In this study, we investigated the 
cardiac autonomic control in a naturally-occurring model of mitral insufficiency by 
means of individual responses to oculocardiac reflex. Indices of heart rate variability 
(MRR, SDNN, RMSSD and VVTI) were calculated from 5-minute ECG tracings 
obtained before and after ocular compression. After compression, a significant 
increase in SDNN, RMSSD and VVTI was documented in healthy control animals. 
Also, an increase in these indices was shown in asymptomatic dogs with remodeled 
hearts, but no variation was seen in symptomatic animals. While only VVTI percent 
change (before-after) was different between controls and diseased dogs, all other 
parameters showed a tendency to behave differently in the symptomatic group. Our 
results documented a CHF-dependent autonomic dysfunction in a model of valve 
insufficiency.  
KEYWORDS  
Parasympathetic withdrawal, sympathetic activation, congestive heart failure, 
autonomic nervous system, oculocardiac reflex 
INTRODUCTION 
_______________  
 
2
 Written in accordance with the guidelines of Journal of Comparative Physiology, available at 
http://www.springer.com/life+sciences/animal+sciences/journal/359 
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Heart rate (HR) is determined by the rate of sinoatrial (SA) nodal discharge 
and autonomic tone influence (Hamlin, 1999). Therefore, parasympathetic and 
sympathetic nervous impulses are responsible for decreases and increases in HR, 
respectively (Montano et al, 2001). When vagal centers in the medulla oblongata are 
stimulated, acetylcholine binds to receptor sites present in the SA node, decreasing 
the discharge rate. Similarly, the stimulation of sympathetic centers in the medulla 
produces norepinephrine that binds to β1 receptors sites at the SA node, increasing 
heart rate (Hamlin, 1999). The autonomic influence to the heart determines the 
adaptive circadian variations of HR, which is a result of the prevailing balance of the 
autonomic impulses in the SA node (Montano et al, 2001). 
The oculocardiac reflex is the heart’s physiological response to digital 
compression of the eyeballs. Described in 1908 by Ashner and Dagnini, it consists of 
a vagal maneuver obtained through the indirect stimuli of the ophtalmic branch of the 
trigeminal nerve, causing negative chronotropic and inotropic responses in healthy 
subjects. The reflex, primarily described in human beings, has recently been 
characterized in dogs and rabbits (Giannico et. al, 2014). 
Congestive heart failure (CHF) is a syndrome to which most cardiovascular 
disorders tend to evolve in advanced conditions. In CHF, as a result of structural, 
neural and electrophysiological remodeling, heart rate undergoes a sustained 
increase in response to autonomic imbalance (Tomaselli et al, 1999). Due to a slight 
fall in systemic arterial pressure caused by the failing heart, vagal restraint on heart 
rate is reduced, from either decreased stretching or diminished function of arterial 
baroreceptors. The levels of circulating cacthecolamines are also elevated in heart 
failure syndrome, which in turn increase sympathetic activation (Amorim et al, 1981). 
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This dysregulated autonomic tone leads to increases in resting HR, which is known 
to interfere in the prognosis of CHF (Floras et al., 2009).  
Sustained sympathetic activation and parasympathetic withdraw have been 
characterized in numerous cardiovascular diseases, and the imbalance is considered 
an aggravating factor in circulatory failure (Nolan et al, 1998; Cohn et. al, 1984). 
Numerous measures of autonomic function have been proposed, especially due to 
their value in determining prognosis (Saul et al, 1988). Through surgical and 
pharmacological means, many researches have focused on documenting the precise 
mechanisms of impaired autonomic function in CHF (Ogawa et al, 2007; Sosunov et. 
al, 2001;Eckeberg et al, 1971). Nevertheless, the exact role played by the autonomic 
imbalance in the progression of cardiac diseases, or vice versa, remains unclear. 
Therefore, in this investigation we sought to evaluate the reliability of a novel way to 
assess the level of autonomic imbalance in CHF patients. Dogs with a naturally-
occurring degenerative mitral valve disease were recruited, and their individual 
response to the oculocardiac reflex was used as a surrogate for the autonomic 
cardiac control. 
 
MATERIAL AND METHODS 
Dogs recruited for this prospective transversal observational study were 
selected among patients admitted for regular cardiac evaluation at a veterinary 
teaching facility. All procedures were previously approved by the institutional Animal 
Use Committee, and complied with the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals.  
In order to be included in the study, the diagnosis of naturally-occurring mitral 
insufficiency was required, which was based on the echocardiographic criteria of 
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impaired valvar anatomy and function (Chetboul and Tissier, 2012). Dogs with 
echocardiographic evidence of any congenital or acquired cardiac disease other than 
degenerative mitral valve disease were excluded from the study, along with patients 
with history of intra-thoracic or abdominal tumors, ophthalmologic disorders, such as 
glaucoma, cataract and ulcerated corneas, as well as brachycephalic dogs. Once 
recruited, the dogs were subdivided based on two criteria: cardiac morphology and 
clinical history concerning signs attributable to CHF. In this regard, three groups were 
created to best describe the study population: No Remodeling (NR), Remodeled but 
still Asymptomatic (RA) and Remodeled and Symptomatic (RS) patients. Also, 
healthy animals lacking signs of valvular dysfunction were recruited as controls. All 
echocardiograms were carried out by experienced veterinary cardiologists using an 
ultrasonography system (MyLab 30 – Esaote, Genova, Italy) equipped with 5.0 MHz 
and 7.5 MHz phased array transducers (P240 and P023 reference – Esaote, 
Genova, Italy). 
Once enrolled into the study, ECG tracings were acquired for each patient, 
with the dog positioned in right lateral recumbency and maintained in position by 
gentle physical restraint. Electrodes were attached to the skin and wet with alcohol to 
improve electrical conduction. The left arm and right arm electrodes were placed at 
the elbows, while the left leg and right leg electrodes were placed at the stifles. The 
electrodes used were toothless alligator-types to reduce discomfort. ECG was 
performed continuously and uninterrupted for five minutes. During the last minute, 
manual ocular compression was applied by exerting continuous digital force using 
the thumb over the superior eyelid in both eyes together, until the run of five minutes 
was over. To avoid interinvestigator discrepancy, ocular compressions were made by 
the same investigator, which was blinded to the patient’s clinical condition, in all 
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dogs. Bad quality recordings and ECG tracings where arrhythmias prevented a 
continuous run of 20 R-R intervals of sinus rhythm were not used in the study 
Once the recording was over, the ECG tracing was used to calculate the mean 
RR interval (MRR), the standard deviation of the RR intervals (SDNN), the root mean 
square of the successive differences in RR intervals (RMSSD) and the vasovagal 
tonus index (VVTI). The calculation of these indices were based on the following 
equations: 
MRR =  ̅  
 
   
 ∑          
SDNN = √
 
   
∑ [      ]̅      
RMSSD = √
 
   
∑ [           ]      
VVTI = NL [VAR (R-R1 – R-R20)] 
Each index was calculated twice for every tracing, the first one before and one 
the other one twenty seconds after the beginning of ocular compression. Also, 
echocardiographic indices of congestion and cardiac function were also documented. 
These included the left atrium-to-aorta ratio (LA/Ao), body weight-indexed left 
ventricular internal diameter in diastole and systole (BW-indexed LVd and BW-
indexed LVs), wall stress index in diastole and systole (WSId and WSIs), fractional 
shortening (FS%), mitral E wave velocity (mitral E), mitral E-to-A ratio (mitral E/A), 
isovolumic relaxation time (IVRT) and mitral E-to-IVRT ratio (E/IVRT), for posterior 
correlation.  
All data underwent the Shapiro-Wilk normality test. Either an analysis of 
variance followed by Tukey´s multiple comparison test or the Kruskal-Wallis test 
followed by Dunn’s test was used to investigate differences between groups. Later, 
either the Mann-Whitney or the T test was used to compare pre and post OCR data 
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for each index, in every group. The percent change of every surrogate using the 
variation between pre and post OCR values was also analyzed, and the Kruskal-
Wallis test followed by Dunn’s test was used to compare this data among groups. 
Finally, either the Pearson’s or the Spearman’s test was used to assess whether 
correlations existed between the percent changes of each index and the 
echocardiographic parameters of congestion and cardiac function. All analyses were 
performed using the software GraphPad Prism (Version 5.0 - San Diego, CA, USA) 
using default settings.  For all analyses, the level of significance was defined as 
P<0.05. 
 
RESULTS 
Sixty-eight client-owned dogs were recruited for the study. Several breeds 
were represented, and the age and body-weight of the animals ranged 1-16 years 
and 2.5-32 kg, respectively. Beagles (8/68), Dachshunds (6/68) and Miniature 
Pinschers (5/68) were overrepresented in the study population. No difference was 
found between groups regarding weight (P=0.3943), but the animal’s age was 
considered different between the control and the RS group (P=0.0074). Descriptive 
statistics of the studied population is summarized on Table 1.  
 Sixteen healthy dogs were used as controls, while 31, 10 and 11 animals were 
assigned into groups NR, RA and RS, respectively. The box plots in Figure 1 
demonstrate how the OCR interfered with the surrogates of autonomic balance in all 
dogs regardless of cardiac condition. Interestingly, a significant decrease was found 
to exist between groups when comparing the values of all four parameters 
documented during ocular compression. For every index, the symptomatic group 
differed statistically from control and NR groups. Also, in the NR group, ocular 
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compression significantly increased SDNN (from 49.7 to 87.3), RMSSD (from 289.7 
to 506.4) and VVTI (from 8.1 to 8.9), while in healthy controls, an increase was 
documented in VVTI (from 8.1 to 8.9). No significant variation, however, was seen in 
remodeled groups.  
When the before-after percent change was analyzed, a significant difference 
between groups was only documented for VVTI (P=0.0419). Interestingly, in spite of 
the absence of significant changes, the percent change of the other surrogates 
showed an obvious tendency to behave in the opposite way in the symptomatic 
group when compared to the asymptomatic and control dogs, as shown in Figure 2. 
In regards to echocardiographic indices of congestion and function, weak 
negative correlations were found between SDNN and WSIs (R: -0.2508), LA/Ao (R: -
0.3558) and Mitral E (R: -0.2714), as well as between RMSSD and BSA-indexed LVs 
(R: -0.2695), WSIs (R: -0.3188) and LA/Ao (R: -0.2810). VVTI was the index with 
most significant correlations, as shown in in Figure 3. On the contrary, no correlation 
existed between MRR and the echocardiographic data. 
 
DISCUSSION 
 Congestive heart failure is known to be characterized by autonomic 
imbalance, which results in sustained elevation and diminished variability of heart 
rate (Stein et al, 1994). In this study, we sought to characterize such autonomic 
imbalance by means of a reduced response to a vagal maneuver in a naturally-
occurring model of mitral valve insufficiency. The oculocardiac reflex, first described 
in people by Ashner and Dagnini (1908), is one of the peripheral subtypes of the 
trigeminal cardiac reflexes, and an important cause of profound bradycardia during 
eye surgery, especially in pediatric procedures (Espahbodi et al., 2015). Also, a 
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recent study that investigated the OCR in dogs demonstrated that manual 
compression of the eyeballs, either together or individually, results in significant 
decreases in heart rate in that species (Giannico et al, 2014).  
  Experimental evidence of increased sympathetic and reduced vagal tone have 
encouraged the development of quantitative markers of autonomic activity (Task 
Force, 1996). Heart rate variability (HRV) is an important measure of autonomic tone 
defined as the fluctuation time between normal sinus beats (RR intervals) (Vanderlei 
et. al, 2009). Although assessing the autonomic nervous system is not simple, HRV 
measurements have proved to be clinically useful, as analyses of beat-to-beat 
changes in HR provide sensitive and early information of impaired cardiac function, 
even before clinical signs become overt (Task Force, 1996). HRV indices are 
normally obtained by linear methods of either time or frequency domain analysis 
(Vanderlei et al., 2009). The time-domain analysis consists of statistical calculations 
based on normal RR intervals. In this research, we used the mean of all RR intervals 
(MRR), the standard deviation of all normal RR intervals (SDNN), the root mean 
square of the successive differences in RR intervals (RMSSD) and the vasovagal 
tonus index (VVTI), which have all been used to assess autonomic dysfunction in 
dogs (Lopez-Alvarez et. al, 2014; Oliveira et al., 2012; Calvert et al, 1998; 
Häggström, 1996), as well as in human beings (Takase, 2010; Vanderlei et al., 2009; 
Lahiri et al., 2008 Task Force, 1996). However, this investigation is the first to assess 
how a vagal maneuver interferes with these parameters. While SDNN is influenced 
by the short-term high frequency variations and low frequency components, reflecting 
total autonomic activity, only high frequency variations, which are normally related to 
parasympathetic influence, are thought to play a role in the other three parameters 
(Task Force, 1996). 
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In our study, the symptomatic group responded differently when undergoing 
the digital ocular compression as compared to every other group. The lack of 
response to the OCR in RS group dogs, as demonstrated by the absence of 
significant changes in all four parameters, is in accordance with the parasympathetic 
withdrawal in heart failure patients, primarily described by Eckberg et. al (1971). 
Since then, this information has been sustained by many studies that assessed 
autonomic function in CHF in various species (Schwartz et al., 2011, Floras et. al, 
2009; Little et. al, 2005). More importantly, this finding illustrates not the lack of vagal 
activity, but rather the diminished response to parasympathetic stimuli in these 
patients. Also, the lack of significant difference between the symptomatic and the 
remodeled but asymptomatic group for MRR and VVTI supports the theory that some 
grade of autonomic imbalance in cardiovascular disorders precedes its clinical 
evidence (Task Force, 1996).  
When it comes to the before-after analyses within a group, the parameters 
documented in the RS group not only appeared to respond less to the oculocardiac 
reflex, but rather behaved the exact opposite way, showing a clear tendency to 
increase with the vagal maneuver. This interesting finding might be attributable to the 
previously mentioned parasympathetic withdrawal together with a subtle sympathetic 
activation due to discomfort related to eyeball compression, which is likely irrelevant 
in dogs with a still preserved vagal response. However, the other and more intriguing 
explanation is that, in addition to parasympathetic withdrawal, patients in CHF are 
also presented with an increased sustained sympathetic activation (Schwartz et al., 
2011, Floras et. al, 2009; Ishie et al., 1998). This hypothesis becomes clearer when 
considering the percent variation of the surrogates obtained for each group of our 
study. The exact opposite behavior of the symptomatic group is most likely a result of 
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sustained sympathetic tone, rather than transitional sympathetic activation. In 
addition, the clear similarity between the NR and RA groups and the control healthy 
group, as opposed to the RS dogs, suggests that, unlike parasympathetic withdrawal, 
which appears to be present at initial stages, the sustained sympathetic activation is 
more evident in overtly affected patients. Similar findings have been previously 
documented in people in CHF (Cohn et.al, 1984; Binkley et la, 1991) 
The significant correlation between the before-after percent variation of the 
surrogates of cardiac autonomic regulation and the echocardiographic indices of 
congestions and function supports the theory that individual response to OCR 
diminishes with the progression of cardiac disease. In severe cases of mitral valve 
regurgitation, volume overload leads to left atrial and ventricular remodeling, both of 
which are associated with the clinical onset (Reynolds et al, 2012). Many 
echocardiographic indices tend to become altered when a still asymptomatic mitral 
insufficient dog progresses into symptomatic CHF (Chetboul et. al, 2012). Therefore, 
the significant correlations found in this study are likely supportive of decreased 
parasympathetic role as CHF becomes overt. This finding is in accordance with data 
previously documented in people (Binkley et al., 1991; Eckberg et. al, 1971), dogs 
(Little et al., 2005) and rats (Nihei et al., 2005).   
An important limitation of this research is the impossibility to control external 
factors that potentially interfere with autonomic tone, such as stress and fear. Most 
dogs enrolled in this study were calm and quiet during the procedure, and appeared 
to tolerate the ocular compressions. However, some animals appeared more 
reluctant to physical restraint and more uncomfortable by the end of the maneuver, 
causing an intensification of sympathetic tone.  
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In this study, dogs with naturally-occurring mitral valve insufficiency were used 
as a model of heart disease leading to CHF, with the purpose of investigating 
autonomic imbalance. The vagal maneuver, represented by a manual compression 
of the eyeballs, was a reliable technique to demonstrate the deterioration of cardiac 
autonomic regulation as mitral insufficiency progresses towards congestive heart 
failure. Dogs in congestive heart failure were shown to develop signs of 
parasympathetic withdrawal and an increased sustained sympathetic activation. 
These findings contrast with both the asymptomatic and control dogs, in which lack of 
parasympathetic response to ocular compression was not observed. Although many 
questions remain regarding the exact influence of autonomic limbs in cardiovascular 
disorders, we believe this research based on the response to a simple vagal 
maneuver helps to shred a light in how the autonomic nervous system behaves in 
congestive heart failure syndrome. 
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TABLES AND FIGURES 
Table 1: Descriptive statistics (either mean/SD or median/IQR) of the recruited population subdivided 
in accordance with the echocardiographic and clinical criteria in healthy controls, and mitral insufficient 
dogs with no cardiac remodeling (NR), remodeled hearts but still asymptomatic (RA) or remodeled 
heart and symptomatic (RS). 
 
Control  
(n=16) 
NR 
(n=31) 
RA 
(n=10) 
RS 
(n=11) 
P 
Age  
(years) 
2.2 
(1.5-8.0) A 
11.0 
(9.0-13.0) B 
11.0 
(8.5-12.0) B 
13.0 
(12.0-14.2) B 
<0.0001* 
Sex  
(F/M) 
10/6  
(63%/34%) 
18/13 
(58%/42%) 
7/3 
(70%/30%) 
5/6 
(45%/55%) 
- 
Weight  
(kg) 
9.0 
(9.0-17.0) 
9.7 
(5.3-13.7) 
8.6 
(5.8-13.6) 
7.1 
(5.1-9.0) 
0.1028 
BSA indexed LVd 
(mm/m2) 
62.5 
(15.3) A 
67.3 
(17,2) A 
75.7 
(14.9) AB 
90.6 
(17.0) B 
0.0003 
BSA indexed LVs 
(mm/m2) 
36.2 
(24.7-42.6) 
34.4 
(29.3-39.8) 
40.7 
(34.6-46.3) 
41.7 
(37.0-49.9) 
0.0906* 
WSId 3.8 
(1.4) 
3.6 
(0.9) 
4.1 
(0.9) 
4.1 
(1.0) 
0.4128 
WSIs 1.3 
(0.3) 
1.3 
(0.4) 
1.3 
(0.7) 
1.3 
(0.4) 
0.9102 
FS 
(%) 
43.2 
(5.9) A  
46.9 
(8.8) AB  
43.2 
(10.0) AB  
51.9 
(6.5) B  
0.0327 
LA/Ao 
 
1.2 
(1.1-1.3) A  
1.1  
(1.0-1.2) A 
1.6  
(1.4-1.7) B 
2.1  
(1.9-2.3) B 
<0.0001* 
Mitral E  
(cm/s) 
82.8 
(19.1) A 
66.4 
(10.7) B 
92.5 
(18.6) A 
151.9 
(30.5) C 
<0.0001 
Mitral E/A 
 
1.4 
(1.0-1.6) AB 
0.9  
(0.7-1.2) A 
1.1  
(0.8-1.4) A 
2.3  
(1.6-3.2) B 
<0.0001* 
IVRT  
(ms) 
58.0 
(40.2-56.2) 
51.0 
(43.0-60.5) 
51.0 
(41.5-51.2) 
35.0 
(17.5-49.5) 
0.1514* 
E/IVRT 
 
1.5 
(1.1-2.4) A 
1.3  
(1.1-1.6) A 
1.7 
(1.4-2.2) AB 
3.9 
(2.5-9.6) B 
<0.0001* 
BSA indexed LVd: body surface area indexed left ventricular internal diameter in diastole; BSA indexed LVs: 
body surface area indexed  left ventricular internal diameter in systole; WSId: wall stress index in diastole; 
WSIs: wall stress index in systole; FS: fractional shortening; LA: left atrium; Ao: aorta; E: E wave; A: A wave; 
IVRT: isovolumic relaxation time *Non parametric analysis 
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Fig 1 - Box-plots depicting the effect of oculocardiac reflex (OCR) on (A) mean RR interval (MRR), (B) 
the standard deviation of the RR intervals (SDNN), (C) the root mean square of the successive 
differences in RR intervals (RMSSD) and (D) the vasovagal tonus index (VVTI), which were used as 
surrogates for autonomic control in healthy control dogs and mitral insufficient dogs with no cardiac 
remodeling (NR), remodeled hearts but still asymptomatic (RA) or remodeled heart and symptomatic 
(RS). Dashed boxes represent the parameters recorded after OCR. Outliers are shown. (―+‖ 
represents de mean). 
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Fig 2 - Median percent change (before-after) of the surrogates used to assess autonomic balance in 
healthy control dogs and mitral insufficient dogs with no cardiac remodeling (NR), remodeled hearts 
but still asymptomatic (RA) or remodeled heart and symptomatic (RS) undergoing manual ocular 
compression to induce the oculocardiac reflex. 
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.
 
Fig 3 – Scatter plots depicting the significant correlations obtained between the percent change in 
VVTI and (A) the left atrium-to-aorta ratio, (B) mitral E wave, (C) isovolumic relaxation time and (D) 
mitral E wave-to-isovolumic relaxation time ratio. 
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CHAPTER 3 - QT Instability, an Indicator of Augmented 
Arrhythmogenesis, Increases With The Progression of Mitral Valve Disease in 
Dogs3 
 
ABSTRACT 
Objectives: To investigate the occurrence of prolongation and/or instability of the QT 
interval in dogs with naturally-occurring mitral insufficiency, and to assess whether 
these findings are associated with an increased predisposition to augmented 
ventricular arrhythmogenesis.  
Animals: 167 dogs diagnosed with myxomatous mitral valve disease that met study 
inclusion criteria. 
Methods: Echocardiographic data and 5-minutes ECG tracings were gathered. Fifity 
consecutive QT intervals measured from sinus beats were recorded for each dog. 
Both heart rate-corrected and uncorrected QT intervals were used to calculate the 
average QT (QTa) and QT variance (QTv), as well as total instability (TI), short-term 
instability (STI), and long-term instability (LTI) using a previously reported technique. 
Analysis of variance and Kruskal-Wallis test followed by Tukey and Dunns test, 
respectively, were used to investigate differences between disease stages in the 
studied population, and Spearman’s test was used to assess existing correlations of 
such indices and the echocardiographic data. Sensitivity and specificity of QTa, QTv, 
TI, STI and LTI in identifying arrhythmias and remodeling was calculated. Follow-up 
from referring veterinarians was obtained by questionnaire, and progression and 
survival were analyzed using Kaplan-Meier curves. 
_______________  
 
3
 Written in accordance with the guidelines of Journal of Veterinary Cardiology, available at 
https://www.elsevier.com/journals/journal-of-veterinary-cardiology/1760-2734/guide-for-authors 
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Results: An increase related to disease progression was documented for every 
index studied, with significant difference between B1 and B2 dogs for QTa, and 
between B1 and C dogs for all the rest. The studied also demonstrated that QTa and 
STI were the indices that best distinguished remodeled from dilated hearts, and 
ventricular arrhythmias from only sinus rhythms, respectively. Dogs with QTa >310 
and STI >7.9 were shown to be slightly (15%) and moderately (30-45%) more prone 
to developing ventricular arrhythmias, respectively. A QTa >300 was able to 
discriminate B1 from B2/C with a sensitivity of 61% and specificity of 70%. The use of 
QT intervals corrected for heart rate lead to more significant results, as opposed to 
results obtained from uncorrected QT intervals. All indices in exception of LTI 
showed prognostic value, with increases significantly relating to all-cause mortality. 
Conclusion: Quantification of beat-to-beat QT instability clearly demonstrated 
changes in short-term, long-term and total instability. Stage C of MMVD dogs are 
presented with higher STI, which results in a 3.71 times increase in probability of 
developing ventricular arrhythmias when values over 7.9 are reached. Increased 
indices of QT prolongation and instability are significantly related to mortality and 
may be useful as prognostic surrogates in MMVD patients. 
 
KEYWORDS: arrhythmias, electrocardiography, repolarization, congestive heart 
failure, prognosis 
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Abbreviations 
 
ACVIM American College of Veterinary Internal Medicine 
Ao aorta 
BW bodyweight 
CHF congestive heart failure 
FS% fractional shortening 
IVRT isovolumic relaxation time 
LA left atrium 
LTI long-term instability 
LVd left ventricle in diastole 
LVs left ventricle in systole 
MMVD myxomatous mitral valve disease 
MVP mitral valve prolapse 
PVC premature ventricular complexes 
QTa average QT 
QTc corrected QT  
QTv QT variance 
QTVI QT variability index 
ROC receiver operating characteristic  
STI short-term instability 
TI total instability 
WSId wall-stress index in diastole 
WSIs wall-stress index in systole 
 
INTRODUCTION 
Sudden cardiac death, frequently caused by ventricular arrhythmias, is an 
important concern in cardiovascular medicine, since it is responsible for nearly half of 
the mortality in patients with structural cardiac diseases [1]. Although implantable 
cardioverter defibrillators are currently the most effective therapy for patients at risk of 
dying suddenly [2], a precise method to identify patients that would benefit from 
prophylactic implantation remains undiscovered [3]. The elucidation of the 
electrophysiological events underlying rhythm disorders may provide surrogate 
markers that are able to predict the occurrence of life-threatening arrhythmias in 
these patients, in order to improve prevention and/or optimize clinical and surgical 
approach [4].  
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The QT interval is the electrocardiographic representation of the total 
ventricular activity, and is affected by repolarization disorders [5]. Unstable 
repolarization dynamics has been hypothesized to play a role in the generation of 
ventricular arrhythmias, which first led Berger and colleagues [6] to create a non-
invasive measure of repolarization known as QT variability index (QTVI). Due to their 
promising results regarding arrhythmia risk stratification in ischemic and non-
ischemic dilated cardiomyopathy, QTVI has since been applied to a wide variety of 
subjects with cardiovascular disease. Also, it has inspired the development of novel 
methods aimed at assessing the risk of augmented arrhythmogenesis and sudden 
cardiac death [7,8]. 
Prolongation and increased variability of the QT interval have both been 
described in a series of cardiac conditions [9,10,11,6]. In mitral valve prolapse 
(MVP), the most common valvular disease in human beings, especially in the young, 
repolarization abnormalities have been documented, with prolongation and 
dispersion of the QT interval increasing as the disease progresses [12,13]. Although 
MVP is a predominantly benign condition, sudden death is a significant complication, 
due to a probable arrhythmogenic underlying mechanism. The etiology of these 
arrhythmias seems multifactorial, including anatomical substrate (myocardial 
stimulation through prolapsed leaflets and ventricular dilation) and a disrupted 
autonomic nervous system [14]. 
When it comes to veterinary medicine, myxomatous mitral valve disease 
(MMVD) is the most common cause of mitral regurgitation in dogs, and also 
represents the most frequent acquired cardiac disease in that species [15]. Due to 
macro and microscopic similarities, as well as an analogous progression, MMVD in 
dogs has been proposed as a spontaneous animal model of MVP [16]. Researches 
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involving electrocardiographic recordings have documented that the occurrence of 
ventricular arrhythmias increases significantly with the progression of the disease, 
being most commonly diagnosed in dogs in congestive heart failure (CHF) as 
compared to those in the earlier stages of the disease [17]. Prolongation of the QT 
interval is described in dogs with ventricular arrhythmias, particularly in those under 
treatment with class I or III antiarrhythmics, such as sotalol and quinidine [5]. Also, 
increases in QT interval and QT variability have been identified in dogs with heart 
failure in a model of pacing-induced tachycardia [18]. Nonetheless, the prolongation 
and instability of the QT interval in dogs with naturally-occurring mitral valve disease 
is yet to be documented. 
With this in mind, in this study the authors hypothesized that symptomatic 
MMVD dogs would exhibit an augmented instability of QT interval, which would make 
them more prone to developing ventricular arrhythmias. Therefore, the purpose of 
this study was three-fold: 1) To investigate whether dogs with MMVD develop a 
prolongation and/or instability of the QT interval in accordance with the progression 
of the disease; 2) To assess how the indices of QT instability relate to ventricular 
arrhythmias and the echocardiographic indicators of cardiac remodeling and function; 
3) To evaluate the role of QT instability indices as prognostic surrogates for mortality 
and the development of cardiac-related clinical signs in dogs with naturally-occurring 
mitral valve disease. 
 
ANIMALS, MATERIAL AND METHODS 
Dogs recruited for this prospective cross-sectional observational study were 
selected among patients admitted for regular cardiac evaluation at a veterinary 
teaching facility. All procedures were previously approved by the institutional Animal 
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Use Committee, and complied with the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals.  
In order to be included in the study, the diagnosis of MMVD at any stage was 
required, which was based on clinical history and the echocardiographic criteria of 
impaired valvar anatomy and function [19]. Dogs that lacked valvar commitment and 
those with echocardiographic evidence of any congenital or acquired cardiac disease 
other than MMVD were excluded from the study, along with patients undergoing 
antiarrhythmic therapy at time of diagnosis. Some echocardiographic parameters, 
including left atrium-to-aorta ratio (LA/Ao), body weight-indexed left ventricular 
internal diameter at end-diastole and end-systole (BW-indexed LVd and BW-indexed 
LVs), wall stress index in diastole and systole (WSId and WSId), fractional shortening 
(FS%), mitral E wave peak velocity (mitral E), mitral E-to-A ratio (mitral E/A), 
isovolumic relaxation time (IVRT) and mitral E-to-IVRT ratio (E/IVRT) were also 
recorded for each dog for posterior correlation with the QT parameters. All 
echocardiograms were carried out by experienced veterinary cardiologists using an 
ultrasonography system (MyLab 30 – Esaote, Genova, Italy) equipped with 5.0 MHz 
and 7.5 MHz phased array transducers (P240 and P023 reference – Esaote, 
Genova, Italy). 
After the selection, ECG tracings were acquired for each patient using a 
computer-based ECG recorder (ECGP V6, TEB – Brazilian Electronic Technology 
Ltda., São Paulo, SP, Brazil). The dogs were placed in right lateral recumbency and 
maintained in position by gentle physical restraint. The electrodes attached to the 
skin were toothless alligator-types to reduce discomfort, and alcohol was applied to 
improve electrical conduction. The left arm and right arm electrodes were placed at 
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the elbows, while the left leg and right leg electrodes were placed at the stifles. ECG 
was performed continuously and uninterrupted for five minutes.  
ECG tracings were reviewed, and 50 consecutive QT intervals obtained from 
sinus beats were obtained for each dog. Whenever ectopic ventricular 
depolarizations occurred, they were ignored and the QT interval was then obtained 
from the following sinus beat. To avoid inter-observer discrepancy, QT intervals were 
measured by the same investigator, who was also blinded to the patient’s heart 
condition determined by echocardiography and clinical history. Once the 50 QT 
intervals were obtained, they were corrected for heart rate using the method 
described by Bazzet [20]. Following, both corrected and uncorrected QT intervals 
were used to calculate the average QT (QTa) and QT variance (QTv). Also, we 
calculated the total instability (TI), the short-term instability (STI), and the long-term 
instability (LTI) using the technique proposed by Van der Linde and colleagues [7] to 
quantitatively assess QT instability by means of a Poincaré plot. The calculation of 
these indices was based on the following equations: 
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Briefly, the morphological properties of the plot were used to determine the 
indices, based in the distribution of the points in the data cluster, the width being a 
measure of the STI, the length a measure of the LTI and a width-and-length-
dependent parameter the measure of TI. An example of the Poincare plot is 
represented in Figure 1.  
For statistical purposes, the dogs were divided in accordance with the stage of 
MMVD (B1, B2 and C) proposed by the consensus statement of the American 
College of Veterinary Internal Medicine [21], which depended on clinical signs 
attributable to CHF, as well as the echocardiographic evidence of cardiac 
remodeling. All data underwent the Shapiro-Wilk normality test. Data obtained from 
uncorrected and heart rate corrected QT intervals were compared. Either an analysis 
of variance followed by Tukey´s multiple comparison test or the Kruskal-Wallis test 
followed by Dunn’s test was used to investigate differences between disease stages 
in the studied population. Spearman’s test was used to assess whether correlations 
existed between QT indices and heart rate, age, body weight and body surface area, 
as well as between the indices and the echocardiographic surrogates of congestion 
and function. Receiver operating characteristic (ROC) curves were constructed to 
investigate sensitivity and specificity of QTa, QTv, TI, STI and LTI to differentiate 
MMVD dogs with and without previously recognized ventricular arrhythmias, and to 
distinguish patients with dilated hearts from those with no remodeling. Finally, 
Kaplan-Meier curves and the log-rank test were used to assess the prognostic value 
of QT indices concerning the development of clinical signs attributable to congestive 
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heart failure (for B1 and B2 dogs) and the all-cause mortality (for all dogs). All 
analyses were performed using the software GraphPad Prism (version 5.0 - San 
Diego, CA, USA) using default settings.  For all analyses, the level of significance 
was defined as P<0.05. 
 
RESULTS 
In this investigation, we sought to assess QT instability in dogs with MMVD by 
means of a mathematical technique in which sequential QT intervals are used to 
calculate how unstable the electrical activity of the ventricular myocardium is. One-
hundred-and-sixty-seven client-owned dogs were recruited at the end of the study. 
Several breeds were represented, and the age and body-weight of the animals 
ranged from 6-18 years and 2.7-36 kg, respectively. Sixty-six, 64, and 37 animals 
were classified as stages B1, B2 and C, respectively. No difference existed between 
stages regarding weight (P= 0.2286) and age (P=0.721).  
 A significant difference was documented between B1 and C and B2 and C for 
QTv, TI and STI when using both QT and QTc, as shown in Figure 2. When using 
corrected QT intervals, QTv increased from 131.1 (B2) to 265.7 (C). A significant 
increase between the same groups was also documented for TI (14.27 to 18.78) and 
STI (6.98 to 10.54). No difference between groups was found for QTa and LTI when 
using uncorrected QT intervals, but significant difference was found between B1 and 
C (QTa and LTI) and B2 and C (QTa) when using QTc. LTI increased from 9.27 (B1) 
to 12.05 (C), and stage C dogs had a significantly higher QTa (321.3) when 
compared to stage B2 (302.7). For QTa, a difference between B1 (287.0) and B2 
(302.7) was also observed when using QTc, as shown in Figure 2-A. When only the 
visual characteristics of the Poincare plot are taken into consideration, it is also clear 
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that QT instability increases with the progression of MMVD, as shown in Figure 3. 
Considering all analyses, statistic differences were more significant when using the 
heart rate-corrected QT intervals. In general, stage C dogs presented significantly 
higher values for most of the analyzed parameters when compared to stage B1 and 
B2 dogs.  
Only the indices calculated from QT intervals corrected for heart rate were 
used in the correlation tests. All five indices showed moderate positive correlations 
with heart rate, and every index but QTa showed weak negative correlations with 
body weight. QTa was the only index that correlated significantly with age (R: 
0.2128). Weak but significant correlations were found to exist between QTa, QTv, 
STI and TI and the described echocardiographic parameters except for BW-indexed 
LVs. A moderate positive correlation was found between LA/Ao and QTa (R: 0,4294). 
LTI was the index that correlated less with the echocardiographic parameters, only 
weakly doing so with LA/Ao, BW-indexed LVd, WSId, WSIs and FS%. Significant 
correlations and their respective Spearman correlation coefficients are shown in 
Table 2. Scatter plots depicting the most significant correlations (R >0.25) are shown 
in Figure 4. 
Again, only the heart rate corrected QT intervals were used to construct the 
ROC curves. Areas under the curve (AUC) >0.5 were obtained when using QTa and 
STI to differentiate dogs with and without ventricular arrhythmias at time of diagnosis, 
and their corresponding curves are shown in Figures 5-A and 5-B. QTa had an AUC 
of 0.713 (P=0.0348), while STI showed and AUC of 0.6992 (P=0.0455) Also, to 
distinguish dogs with remodeled hearts from those without remodeling, an AUC >0.5 
was documented for each of the five QT indices. Of note, QTa (AUC=0.7121; 
P<0.0001) and QTv (AUC= 0.6799; P<0.0001) were the indices that best 
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discriminated B1 from B2/C dogs, and the ROC curves for these parameters are 
shown in Figures 5-C and 5-D. The cut-off values for these surrogates and their 
respective sensitivity, specificity, and positive likelihood ratio when used to detect the 
presence of ventricular arrhythmias and cardiac remodeling are shown in Tables 3 
and 4, respectively. 
Concerning the development of clinical signs attributable to congestive heart 
failure, none of the calculated indices were able to predict the time needed for B1 
and B2 dogs to become overtly symptomatic. On the other hand, the increase in all 
indices but LTI was associated with increased all-cause mortality. For instance, QTa, 
when a cut-off value of 302 is applied, reflects in a median difference of 105 days in 
survival time, with a hazzard-ratio of 0.4296. Similary, STI reflects a median 
difference of 128.5 with a hazard-ratio of 0.4986 when a cut-off value of 7.5 is 
applied. The results of the prognostic study are shown on Table 5 and the Kaplan-
Meier curves obtained for the significant findings are also shown on Figure 6. 
 
DISCUSSION 
Studies regarding MMVD in dogs have shown an increase in ventricular 
arrhythmias with the progression of the disease, although precise mechanisms are 
yet to be underlined [17]. In our study, we demonstrated that prolongation and 
instability of the QT interval is not only present in these dogs, but increases with the 
disease progression. This finding is most likely involved in the generation of 
ventricular arrhythmias. In the normal heart tissue, myocyte repolarization time is 
uniform at a given rate, and autonomic modulation and occasional changes in 
electrolyte levels cause modest predictable effects on the action potential. In chronic 
conditions such as heart failure, however, there is an increase in beat-to-beat 
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variability in action potential duration, resulting from increased membrane instability, 
steepening of the restitution relationship between the QT and diastolic interval, and 
increased ratio of sympathetic to parasympathetic tone [22]. Intermittent prolongation 
of the QT interval promotes the opportunity for a premature depolarization to arise, 
block in one area, and conduct in an adjacent region. The result is an increased risk 
for reentrant arrhythmias, particularly ventricular fibrillation [23]. 
A few methods for measuring repolarization instability have been described in 
literature, most of them using the standard deviation of QT intervals. The length and 
width of a Poincaré plot have been described as a weighted combination of low- and 
high-frequency power, which can also be used for calculating instability of QT 
intervals [24]. In a study by Van der Linde et al [7], 32 Beagle dogs were given 
increasing doses of a potentially arrhythmogenic anestheti. Their results were 
superior in detecting prolongation and instability of the QT interval, demonstrating a 
higher precision still in pre-arrhythmic states as compared to other methods aimed at 
quantifying Poincaré plots, which have been used to conventionally determine heart 
rate instability [25,26] or ventricular repolarization [27]. 
Increased heart rate is known to have negative correlation with QT intervals, 
which may disguise prolongation and instability. Since dogs in the advanced stages 
of the disease tend to have increased heart rate owing to autonomic imbalance [28], 
the use of the QT interval corrected for heart rate seems more proper, as the results 
of this study have confirmed. When using corrected QT intervals for calculation, QTa, 
QTv, TI, STI and LTI all pointed to a significant difference between stages B1 and C 
regarding the potential to developing arrhythmia.  
Even though it may seem obvious, this study was able to demonstrate 
objectively that both prolongation (QTa) and instability of the QT interval increase 
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with the progression of MMVD. Stage C dogs are significantly more prone to 
ventricular arrhythmias, in agreement with the findings of Crosara et. al [17]. Also, our 
study shows that, as it happens with the frequency of ventricular arrhythmias, QT 
instability is higher in advanced stages, and repolarization disorders may actually 
play a role in the development of these arrhythmias in symptomatic patients. Also, 
the significant difference between B1 and B2 found for QTa may indicate that 
prolongation of the QT interval precedes instability, therefore being the first indicator 
of repolarization disorder in an otherwise asymptomatic animal. Similar findings have 
been described in people with MVP. In a Holter study of autonomic profile and QT 
dynamicity, Digeos-Hasnier et al. [12] found that prolongation of the QT interval 
appears precociously in MVP patients, even in non-symptomatic stages, when 
compared to a control group. This finding increases the similarities and straightens 
the role of dogs with MMVD as a naturally occurring animal model of MVD. 
In regards to the echocardiographic data, the identification of significant 
correlations with the QT instability indices supports the hypothesis that prolongation 
and instability of the QT interval increases with disease progression.  In severe cases 
of mitral valve regurgitation, volume overload leads to left atrial and ventricular 
remodeling, both of which are associated with the onset of clinical signs attributable 
to cardiac disease [29]. The significant correlations with indices of congestion and 
function, especially the moderate positive correlation between QTa and LA/Ao (a 
surrogate with known prognostic value in MMVD), are supportive of repolarization 
disorders increasing as clinical signs become more severe [29]. 
Concerning sensitivity and specificity, an AUC >0.5 was found for QTa and 
STI when the indices were used to discriminate dogs with and without ventricular 
arrhythmias. Dogs with QTa >310 (sensitivity:56%/specificity:71%), and STI >7,9 
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(sensitivity:67%/specificity:65%) were shown to be slightly (15%) and moderately (30-
45%) more prone to developing ventricular arrhythmias, respectively. Since QTa is 
the index that best reflects prolongation of the QT interval, which precedes instability 
and clinical evidence as this study has shown, QTa may be useful as an early 
indicator of repolarization disorders in still asymptomatic patients. As the disease 
progresses and prolongation of the QT interval evolves to instability, STI seems to be 
the most effective index to identify patients in more advanced stages most likely to 
develop ventricular arrhythmias. As shown in the odds ratio column in Table 4, 
MMVD dogs with STI> 7.9 are 3.7 times more likely to present ventricular 
arrhythmias. These parameters, to the author’s knowledge, are the first 
electrocardiographic indices with predictive value for ventricular arrhythmias in dogs 
with myxomatous mitral valve disease.     
Also, QTa was the index that best discriminated MMVD dogs with remodeled 
and non-remodeled hearts. A QTa >300 was able to discriminate B1 from B2/C with 
a sensitivity of 61% and specificity of 70%, with dogs being 3.6 times more likely to 
show cardiac dilatation. Although echocardiography is the gold standard for 
evaluation of cardiac anatomy and function, the existence of indices of remodeling 
obtainable from routine electrocardiographic tracings may aid in clinical approach 
when echocardiography may be unavailable.  
Finally, another important result of this study was the significant correlations 
found between most of the studied indices and all-cause mortality. Diagnosis and 
staging of MMVD, with the evolution and increasing accessibility to 
echocardiography, has become more and more precise. Prognosis, on the other 
hand, due the variable nature of disease progression, is still a challenge [30]. Up to 
date, there is no ideal way of telling if or when an asymptomatic patient with mitral 
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disease will develop CHF, nor how long will it live after that. In this matter, surrogates 
with prognostic value have gained attention, with LA/Ao, heart rate variability and NT-
proBNP serum levels standing out as the most reliable tools [29,31]. In this study, we 
have shown that indices of QT instability, which are easily calculated from standard 
ECG tracings, may also aid in prognosis, offering complementary information for 
determining mortality in affected dogs. 
An important limitation of this research relates to the indices being obtained 
from regular ECG recordings. As we know, paroxysmal ventricular arrhythmias may 
lead to false negative diagnosis when based in five-minute tracings. The use of a 24-
hour Holter monitoring would certainly result in the identification of a higher number 
of animals with ventricular arrhythmias, which might have increased sensitivity and 
specificity of the studied parameters. Also, the use of Holter monitoring with 
automated analysis based on a pre-determined QT duration criteria to quantify 
variability, as proposed by Berger et al. [6] ensures reproducibility. The method 
involving the Poincaré plot used in this study requires a smaller amount of data, 
enabling manual beat-to-beat measuring, which may vary between observers. 
Although the QT intervals were measured by the same investigator in order to avoid 
inter-observer discrepancy, consistent reproducibility of the method requires more 
studies. Another possible limitation was the use of sinus beats that followed 
ventricular ectopic beats in the formulas. Although premature ventricular contractions 
(PVCs) were excluded from the analysis of QT variability, QT dynamics after PVCs is 
poorly understood. It is speculated, however, that premature ventricular contractions 
(PVC) can alter the QT interval within several consecutive cardiac cycles [32]. Finally, 
QT duration was measured only on lead II and, therefore, might carry errors, as 
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measurement of the heart vector on a single ECG lead is never completely reliable 
[33]. 
 
CONCLUSIONS: 
Both prolongation and instability of the QT interval increase with progression 
of mitral valve disease in dogs, and are likely to play a role in the development of 
ventricular arrhythmias in these patients. QTa and STI are, up to date, the only 
parameters obtained from conventional ECG tracings with predictive value for 
ventricular arrhythmias in MMVD dogs. Also, the indices of QT instability may serve 
as prognostic surrogates for mortality.  
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TABLES AND FIGURES 
 
Table 1 - Characteristics of the dog population enrolled in the study. Either mean (SD) or median 
(IQR) are shown. Dogs were divided in accordance with the disease stages proposed by the 
consensus statement of the American College of Veterinary Internal Medicine.  
 
 
MMVD Stage 
P 
B1 B2 C 
N 66 64 37 - 
Age  
(years) 
11  
(6-18) 
12  
(7-18) 
12  
(7-18) 
0.7210 
Sex  
(F/M) 
42/24  
(64%/36%) 
31/33  
(48%/52%) 
21/16  
(57%/43%) 
- 
Body weight  
(kg) 
7.7  
(2.7-36.0) 
7.3  
(3.3-16.5) 
7.2  
(2.9-15.0) 
0.2286 
BW-indexed LVd 
(mm/kg) 
64.9 ± 17.9 A 77.6 ± 20.2 B 98.5 ± 20.1 C <0.0001* 
BW-indexed LVs 
(mm/kg) 
37.9  
(32.9-46.3) A 
40.1  
(34.7-51.3) AB 
49.7  
(40.1-58.3) B 
0.0052 
WSId 
 
3.8  
(3.1-4.3) A 
4.3  
(3.3-5.2) AB 
5.0  
(3.9-5.8) B 
0.0011 
WSIs 
 
1.4  
(1.2-1.7) 
1.4  
(1.2-1.9) 
1.5  
(1.1-1.9) 
0.8252 
FS 
(%) 
45.1 ± 8.8 A 47.3 ± 9.8 AB 50.9 ± 9.3 C 0.0110* 
LA/Ao 
 
1.1  
(1.1-1.2) A 
1.6  
(1.5-1.8) B 
2.1  
(1.9-2.4) C 
<0.0001 
Mitral E  
(cm/s) 
66.5  
(56.7-74.2) A 
96.0  
(75.0-116.0) B 
132.8  
(101.4-171.3) C 
<0.0001 
Mitral E/A 
 
1.1  
(1.1-1.3) A 
1.1  
(0.9-1.3) A 
1.6  
(1.2-2.3) B 
<0.0001 
TRIV  
(ms) 
60  
(48-72) A 
57.0  
(44.0-61.5) A 
33.0  
(19.0-48.5) B 
<0.0001 
E/TRIV 
 
1.1  
(0.8-1.6) A 
1.7  
(1.3-2.1) B 
4.1  
(2.6-7.6) C 
<0.0001 
BW-indexed LVd: body weight-indexed left ventricular internal diameter at end-diastole; BW-indexed 
LVs: body weight-indexed left ventricular internal diameter at end-systole; WSId: wall stress index at 
end-diastole; WSIs: wall stress index at end-diastole and systole; FS: fractional shortening; LA/Ao: left 
atrium-to-aorta ratio; Mitral E: mitral E wave peak velocity (mitral E); Mitral E/A: mitral E-to-A ratio; 
IVRT: isovolumic relaxation time; E/IVRT: mitral E-to-IVRT ratio. (*) parametric analyses 
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Figure 1 - A schematic example of the Poincaré plot and the quantification of QT instability based on 
the distances of a cluster of 50 QT intervals to the center of gravity as proposed by Van der Linde and 
colleagues (2005). The rationale behind the determination of total instability (TI), long-term instability 
(LTI) and short-term instability (STI) is the distance of each individual point to either the center of 
gravity or the identity line. In this example, not all data points are seen because some are exactly the 
same.  
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Figure 2 - Box plots depicting the medians, interquartile ranges and amplitude of (A) average QT, (B) 
QT variance, (C) short-term instability, (D) long-term instability and (E) total instability in dogs in 
different stages of myxomatous mitral valve disease. Dashed boxes represent the results calculated 
from heart rate-corrected QT intervals. Outliers are shown. 
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Table 2 - Significant correlations documented between between QT instability parameters and the 
echocardiographic indices of congestion and function. 
 
 QTa QTv TI LTI STI 
BW-indexed 
LVd 
R: -0.1615 
P: 0.0469 
R: 0.2712 
P: 0.0007 
R: 0.2068 
P: 0.0106 
- 
R: 0.2631 
P: 0.0011 
BW-indexed 
LVs 
R: -0.1984 
P: 0.0143 
- - 
R: -0.1779 
P: 0.0283 
- 
WSId 
- 
R: 0.1556 
P: 0.0452 
- - 
R: 0.2111 
P: 0.0063 
WSIs 
- 
R: -0.2214 
P: 0.0040 
R: -0.1839 
P: 0.0173 
R: -0.1617 
P: 0.0368 
R: -0.2010 
P: 0.0092 
FS% 
- 
R: 0.2462 
P: 0.0013 
R: 0.1731 
P: 0.0252 
- 
R: 0.2296 
P: 0.0028 
LA/Ao 
- 
R: 0.2271 
P: 0.0032 
R: 0.1944 
P: 0.0118 
- 
R: 0.1849 
P: 0.0168 
Mitral E 
- 
R: 0.1965 
P: 0.0112 
R: 0.1642 
P: 0.0345 
- 
R: 0.2059 
P: 0.0078 
Mitral E/A 
- 
R: 0.1567 
P: 0.0452 
- - 
R: 0.1606 
P: 0.0405 
IVRT 
- 
R: -0.2271 
P: 0.0224 
- - 
R: -0.3266 
P: 0.0009 
E/IVRT 
- 
R: 0.2065 
P: 0.0393 
- - 
R: 0.2883 
P: 0.0036 
QTa: average QT interval; QTv: QT variance; TI: total instability; STI: short-term instability; LTI: long-
term instability; BW-indexed LVd: body weight-indexed left ventricular internal diameter at end-
diastole; BW-indexed LVs: body weight-indexed left ventricular internal diameter at end-systole; WSId: 
wall stress index at end-diastole; WSIs: wall stress index at end-diastole and systole; FS%: fractional 
shortening; LA/Ao: left atrium-to-aorta ratio; Mitral E: mitral E wave peak velocity (mitral E); Mitral E/A: 
mitral E-to-A ratio; IVRT: isovolumic relaxation time; E/IVRT: mitral E-to-IVRT ratio. 
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Figure 3 – Modified Poincare plots in which a line is connecting the 49 combinations of 50 successive 
QT intervals to depict QT instability of four different patients, in different stages of MMVD. (A) B1 dog 
with a total instability of 12.1; (B) B2 patient with total instability of 14.3; (C, D) C and D dogs with total 
instability of 18.1 and 27.8, respectively. 
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Figure 4 – Scatter plots depicting the most significant correlations (R >0.25) obtained between (A) 
body weight-indexed left ventricular internal diameter at end-diastole and the QT interval variance 
(QTv); (B) body weight-indexed left ventricular internal diameter at end-diastole and the short-term 
instability (STI) of QT interval; (C) isovolumic relaxation time (IVRT) and the STI of QT interval; and 
(D) mitral E wave peak velocity-to-isovolumic relaxation time ratio and the short-term instability of QT 
interval. Linear regression lines are shown. 
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Figure 5 - Receiver operating characteristic (ROC) curves constructed to investigate the sensitivity 
and specificity of the (A) average QT and (B) short-term instability to differentiate myxomatous mitral 
valve disease (MMVD) dogs with and without ventricular arrhythmias. ROC curves constructed to 
assess sensitivity and specificity of the (C) average QT interval and (D) QT variance in differentiating 
MMVD dogs with either remodeled (stages B2 and C) or non-remodeled (stage B1) hearts.  
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Table 3 – Cut-off values, sensitivity, specificity, positive predictive value (PPV), post-test probability, 
accuracy and odds ratio obtained when using either the average QT (QTa) or the short-term instability 
(STI) to differentiate myxomatous mitral valve disease (MMVD) dogs presenting only sinus rhythms 
from MMVD dogs presenting any ventricular arrhythmia. 
 
 Cut-off Sensitivity Specificity PPV 
Post-test 
probability 
Accuracy 
Odds 
Ratio 
QTa 
>297.0 0.78 0.49 0.09 8.97 51.01 3.40 
>300.0 0.78 0.57 0.10 10.45 58.39 4.67 
>305.0 0.56 0.66 0.10 9.62 65.77 2.47 
>310.0 0.56 0.71 0.11 11.11 70.47 3.13 
STI 
>6.7 0.78 0.46 0.08 8.43 47.65 2.95 
>7.9 0.67 0.65 0.11 10.91 65.10 3.71 
>9.0 0.56 0.73 0.12 11.63 71.81 3.36 
>11.0 0.56 0.85 0.19 19.23 83.22 7.08 
QTa: heart-rate corrected average QT interval; STI: short-term instability. 
 
 
Table 4 –Cut-off values, sensitivity, specificity, positive predictive value (PPV), post-test probability, 
accuracy and odds ratio obtained when using either the average QT (QTa) or the QT variance (QTv) 
to differentiate myxomatous mitral valve disease (MMVD) dogs with remodeled (stages B2 and C) and 
non-remodeled (stage B1) hearts. 
 
 Cut-off Sensitivity Specificity PPV 
Post-test 
probability 
Accuracy 
Odds 
Ratio 
QTa 
>292.0 0.74 0.55 0.71 71.43 66.47 3.46 
>295.0 0.73 0.58 0.73 72.55 67.07 3.72 
>300.0 0.61 0.70 0.76 75.61 64.67 3.66 
>302.0 0.57 0.74 0.77 77.33 64.07 3.89 
QTv 
>107.0 0.71 0.53 0.70 69.90 64.07 2.80 
>115.0 0.68 0.58 0.71 71.13 64.07 2.93 
>130.0 0.64 0.62 0.72 72.22 63.47 2.96 
>165.0 0.56 0.73 0.76 76.00 62.87 3.45 
QTa: heart rate corrected QT interval; QTv: heart rate-corrected QT variance. 
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Table 5 – Data obtained from the prognostic study. QT indices were investigated as prognostic 
surrogates concerning the development of clinical signs attributable to congestive heart failure and all-
cause mortality. 
 Criteria Cut-off 
Result 
(days) 
Hazard 
ratio 
95% CI P 
D
e
v
e
lo
p
m
e
n
t 
o
f 
C
li
n
ic
a
l 
S
ig
n
s
 
D
u
e
 t
o
 C
H
F
 
QTa 
< 302 362.0 
0.5322 
0.2677 to 
1.058 0.0720 ≥ 302 225.0 
QTv 
< 162 266.0 
0.7495 
0.3772 to 
1.4890 
0.4104 
≥ 162 234.0 
STI 
< 7.5 225.0 
0.7915 
0.3879 to 
1.6150 
0.5204 
≥ 7.5 250.0 
LTI 
< 10.0 373.0 
0.5674 
0.2906 to 
1.1080 
0.0968 
≥ 10.0 215.5 
TI 
< 14.0 324.0 
0.5526 
0.2715 to 
1.1250 
0.1019 
≥ 14.0 206.0 
A
ll
-c
a
u
s
e
 M
o
rt
a
li
ty
 
QTa 
< 302 279.0 
0.4296 
0.2426 to 
0.7607 0.0038 ≥ 302 174.0 
QTv 
< 162 276.5 
0.4840 
0.2696 to 
0.8691 
0.0271 
≥ 162 174.0 
STI 
< 7.5 276.5 
0.4986 
0.2746 to 
0.9052 
0.0222 
≥ 7.5 148.0 
LTI 
< 10.0 257.5 
0.9418 
0.5583 to 
1.5890 
0.8223 
≥ 10.0 177.0 
TI 
< 14.0 276.5 
0.5657 
0.3248 to 
0.9854 
0.0442 
≥ 14.0 174.0 
QTa: average QT interval; QTv: QT variance; STI: short-term instability; LTI: long-term instability; TI: 
total instability. All parameters were calculated based on heart rate-corrected QT intervals.   
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Figure 6 – Kaplan-Meier curves constructed to investigate whether indices derived from QT interval 
would serve as prognostic surrogates for mortality. A lower (A) heart rate-corrected average QT (QTa), 
(B) QT variance, (C) short-term instability and (D) total instability were significantly associated with 
reduced all-cause mortality in dogs with myxomatous mitral valve disease.  
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